Why Your Retina Specialist Ordered Bloodwork for Clotting Disorders
Clotting Bloodwork After a Retinal Blockage at a Glance
First, the safety part. The blood tests are not urgent. New eye or brain symptoms are. If you have sudden vision loss in one eye, do not wait for lab results. Do not wait for an office visit. Go to an emergency room right away.
- Sudden vision loss in one eye or in both eyes
- A dark curtain or shadow sliding over part of your sight
- New double vision that stays when you cover one eye
- Weakness or numbness on one side of the body
- Slurred speech, a drooping face, or the worst headache of your life
Most people who have this bloodwork drawn never have an event like this. Still, the first hours count. When an artery feeding the retina is blocked, the window in which treatment may help is measured in hours, roughly up to about 4.5 hours from when symptoms start.1 If more time has passed, go anyway, since the stroke risk still needs attention. Stroke risk is highest in the first month after such a blockage, with about 3 to 4 of every 100 people having a stroke in those 30 days.2 If any sign above shows up, call 911.
Your retina doctor found a blockage in a small vessel feeding the retina, the light sensing layer at the back of the eye. The bloodwork asks one question. Is something in your blood making clots form too easily? Doctors call that tendency thrombophilia (clinical: an inherited or acquired condition that raises clotting risk), and the screen is aimed at people whose blockage ordinary risk factors do not explain.3
A retinal vessel is one of the few a doctor can see directly, with no cut and no scan. What shows up there often reflects the rest of your circulation. In one nationwide study of 22,919 people who had a retinal vein blockage, matched against 114,595 people who had not, ischemic strokes were counted at about 431 for every 10,000 people followed for a year, against about 317 for every 10,000 in the matched group.4 Those two numbers sit close together, and the gap between them is why your care team looks past the eye at things like blood pressure, blood sugar and cholesterol.
What a Clotting Disorder Workup Actually Includes
Blood should clot when you are cut and stay liquid the rest of the time. A clotting disorder tips that balance. Some kinds are inherited. Others are acquired, developing later in life. Factor V Leiden is a common inherited kind, carried by 3 to 8 of every 100 people with European ancestry.5 Antiphospholipid syndrome is an acquired kind, in which antibodies attack healthy cells and raise the chance of clots.6
This is not one test but a group, and your doctor picks from it based on your age, your eye findings, and your family history. The table below shows a typical panel.
| Test | What it checks | Type |
|---|---|---|
| Factor V Leiden, prothrombin gene variant | Gene changes that let clots form more easily | Inherited |
| Protein C, protein S, antithrombin | The natural brakes your body puts on clotting | Inherited |
| Lupus anticoagulant, anticardiolipin, beta-2 glycoprotein I | Autoimmune antibodies of antiphospholipid syndrome | Acquired |
| Homocysteine | An amino acid tied to B vitamin levels | Either |
A screen of this shape is what reference texts describe for selected patients after a retinal vein blockage.3
Not every tube is about clotting. Your doctor is also checking the ordinary causes, which are far more common. Standard checks after a central retinal vein blockage include blood pressure, a sedimentation rate, a blood count, a blood sugar and a cholesterol panel.3 After an artery blockage, the sedimentation rate and C-reactive protein are drawn to look for giant cell arteritis, and the carotid arteries are imaged.1
The split changes how a result is used. An inherited variant is fixed for life and can run in families. An acquired antibody can come and go. Lupus anticoagulant can show up briefly after a viral infection, so it counts as persistent only when found on two or more occasions at least 12 weeks apart.7
Why a Retinal Blockage Sets Off This Search
The retina has an artery bringing blood in and a vein carrying it out. A vein blockage backs blood up, so vision often changes over hours to days. An artery blockage cuts the supply off, so vision usually drops fast and without pain. The American Heart Association describes an artery blockage in the retina as a medical emergency, and asks care systems to triage it much as they triage a brain stroke.8
Common causes are checked first, because they explain most cases. High blood pressure, open-angle glaucoma, diabetes and high cholesterol are described as the main risk factors, and about 90 of every 100 patients with this vein blockage are older than 50.3
Testing is targeted, not routine. A clotting screen is described as indicated for patients under 50, for a blockage in both eyes, and for a personal or family history of clots.3 An Italian thrombosis society takes a similar line, suggesting the full antibody panel plus homocysteine when no systemic risk factor is apparent, above all under age 45.9
Age stands in for how likely an ordinary explanation is. A blockage at 34 is harder to explain by wear on the vessels than the same blockage at 74. A blockage in both eyes points to something systemic. Among 1,181 patients under 50 with a new central retinal vein blockage, about 12 of every 100 were found to have a clotting disorder within a year.10 That is a real yield, and it is still a minority.
How to Get Ready for the Blood Draw
Ask, because it depends on which tubes were ordered. Gene tests and antibody tests do not need fasting. Cholesterol and blood sugar often do. Fasting usually means nothing to eat or drink except plain water for 8 to 12 hours.11 A homocysteine test may also call for 8 to 12 hours without food.12 A morning slot helps.
Bring a written list of everything you take, including over the counter products. Blood thinners matter most, because several of these tests read them as an abnormal result. Ask whether to take your usual medicines before a fasting test, and do not stop them unless your provider tells you to stop.11 Never pause a blood thinner on your own to make a result cleaner.
A delay here is a sign of care. Testing during a recent clot, or while a person takes anticoagulants, is uninformative. Natural anticoagulant levels drop after a clot. Warfarin invalidates the protein C, protein S and lupus anticoagulant assays, so those wait about 2 weeks after it stops, and low molecular weight heparins cause false positive lupus anticoagulant results, so testing waits about 24 hours after they stop.13 Direct oral anticoagulants are held at least 48 hours before lupus anticoagulant testing.7 Your prescriber decides that timing, not you.
Bring photo identification, your insurance card, the order, and your medicine list. Drink plain water unless told otherwise, which makes veins easier to find. Bring a snack for afterward, because feeling light-headed after a fasting draw is common.11
What Happens During the Blood Draw
The visit is brief and ordinary. A health care professional takes the sample from a vein in your arm with a small needle, and the draw usually takes less than five minutes.14 A band goes around your upper arm, the skin is cleaned, and you may feel a short sting.
Seeing six or eight tubes lined up is alarming, and it is not a large amount of blood. Different tests need different preservatives, so each gets its own tube. All of them are filled from the single needle already in place.
Both are common and both are manageable. A blood draw carries very little risk, and slight pain or bruising at the needle site usually clears quickly.14 Press firmly for a few minutes and keep the bandage on for a couple of hours.
Making Sense of Your Results
A blood count or a cholesterol panel often returns within a day. Antibody and gene tests go to specialized labs and can take one to three weeks. Providers read blood tests alongside your symptoms, your history and other tests, and blood testing does not always give enough information on its own.14 Ask who will call you, and when.
A clean panel is good news with limits. It makes several clotting disorders unlikely, which is reassuring. It does not rule out every cause of a retinal blockage. Blood pressure, blood sugar and cholesterol still carry most of the weight. Those are the main factors described for this vein blockage.3
A single abnormal value is a signal to look again, not a label. Antibodies must be found on two or more occasions at least 12 weeks apart to count as persistent.7 A diagnosis of antiphospholipid syndrome also needs clinical problems, not antibodies alone.6 A recent clot or a blood thinner can lower protein C and protein S readings for reasons unrelated to any inherited shortage.13
Mostly it changes prevention elsewhere in the body, not the treatment of your eye. Antiphospholipid syndrome is managed long term with blood thinning medicines such as warfarin, heparin or aspirin, and it has no known cure.6 One copy of factor V Leiden raises the yearly chance of an abnormal clot from about 1 in 1,000 to about 3 to 8 in 1,000, and only about 10 of every 100 carriers ever develop one.5
Risks, Cost, and the Honest Limits of This Testing
Set beside most medical tests, this one is gentle. A blood draw carries very little risk, and brief pain or bruising at the needle site is the usual complaint.14 The real costs are your time and whatever your plan charges for specialized assays.
The harm from this panel is rarely the needle. It is a result read out of context. A mistimed draw can label a healthy person as deficient. Levels of the natural anticoagulants fall after a clot and while anticoagulant drugs are taken, which is why the timing rules exist.13 Confirm before committing.
Experts still disagree here, and you deserve to know that. A 2023 hematology guideline on clotting tests issued 23 recommendations, nearly all conditional and based on very low certainty evidence, and suggested testing only in selected settings.15 Routine homocysteine screening is not advised for everyone, since lowering the level has not been shown to reduce heart attack or stroke risk.12
When to Call, and Who Joins Your Care Next
Some symptoms outrank any pending lab. Sudden vision loss, a curtain across your sight, new double vision, one sided weakness, slurred speech or a sudden severe headache all mean an emergency room or 911, without delay. Stroke risk after an artery blockage in the retina is concentrated in the first 30 days, at about 3 to 4 of every 100 people.2 You will not be wasting anyone's time.
Other changes are urgent but not same minute. Call your eye doctor if vision in the affected eye slips further, if you notice new floaters, if the eye turns red and painful, or if pain or swelling starts in one calf. Call the ordering office if two weeks pass with no results.
A clotting workup often widens your care team, which is expected. A hematologist reads an abnormal panel. After an artery blockage, imaging of the carotid arteries is part of the systemic evaluation.1 Ask your retina doctor who is arranging that imaging and who will explain the result, so nothing sits waiting between two offices.
Questions Patients Ask About Clotting Bloodwork
No, and it is fair to want that promise. A normal panel makes several specific clotting disorders unlikely. No blood test can promise the blockage will not return. Nothing in these tubes shows how your retina looks today. That is what the dilated exam and the scans at your follow-up visits are for, so keep those appointments.
Not automatically. It depends on which test and on your history. Antiphospholipid syndrome is managed with blood thinning medicines over the long term, and the diagnosis needs both antibodies and clinical problems.6 For inherited variants the picture is far less settled, with hematology guidance offering mostly conditional advice based on very low certainty evidence.15 A hematologist weighs your bleeding risk against your clot risk first.
Some can and some cannot, which is why the order may be split. Gene tests for factor V Leiden and the prothrombin variant are not affected by medicine. Warfarin invalidates the protein C, protein S and lupus anticoagulant assays, and low molecular weight heparins cause false positive lupus anticoagulant results, so testing is timed around stopping those drugs.13 Do not stop a blood thinner for a lab. Ask the prescriber to coordinate.
Possibly, though the case for testing healthy relatives is weaker than families expect. Only about 10 of every 100 people who carry factor V Leiden ever develop an abnormal clot, and one copy raises the yearly chance from about 1 in 1,000 to about 3 to 8 in 1,000.5 Hematology guidance suggests testing relatives without symptoms only in selected settings, and advises against testing the general population before combined oral contraceptives are started.15 Raise it with a hematologist.
Because a raised level has been linked to vessel damage and clot risk, and a low B vitamin level is easy to correct. A homocysteine test measures an amino acid in the blood, and a high level can point to low vitamin B12 or folate.12 An Italian statement suggests measuring it after a retinal vein blockage when no systemic risk factor is apparent.9
Some tubes can be drawn today. Others are better a few weeks out, so the schedule is staggered on purpose. Blood count, blood sugar, cholesterol and inflammation markers go early. Testing during a recent clot is uninformative, because natural anticoagulant levels fall after the event, so protein C, protein S and antithrombin are usually deferred.13 Antibody results also need repeating at least 12 weeks later.7
More Questions About Results and What Comes Next
They can contribute, and it is worth raising directly. Estrogen containing therapy is a recognized clot risk, and it is one of the few risk factors that can be changed quickly. Hematology guidance advises against testing the general population for clotting disorders before combined oral contraceptives are started, while suggesting testing in selected settings such as a family history of certain deficiencies.15 Do not stop a prescribed hormone on your own.
That outcome is common, and it does not mean the workup failed. Among 1,181 patients under 50 with a new central retinal vein blockage, about 38 of every 100 had clotting tests within 90 days, and about 12 of every 100 were found to have a clotting disorder within a year.10 Most young patients do not turn out to have one. A negative panel narrows the field and redirects attention to blood pressure, sleep apnea, smoking and eye pressure.
Yes. Treatment of the eye is guided by what your retina and your vision look like, not by the blood panel. Whether blood thinning drugs help the eye itself is unsettled, and one thrombosis society declined to grade its recommendations formally because good quality trials are lacking.9 Keep every follow-up your retina doctor books, even if you feel fine.
Coverage varies by plan and by how the order is coded, so check before the draw. Ask the office for the test names and billing codes, then call the number on your insurance card. If cost is a barrier, say so plainly, since a doctor can often stage the panel and start with the tests most likely to change your care.
Take this list to your next visit.
- Which tests did you order for me, and what is each one looking for?
- Why do I fit the profile for clotting tests rather than routine bloodwork alone?
- Do I need to fast, and should I take my usual medicines that morning?
- Am I on anything that could distort these results, and should any tube wait?
- Who calls me with results, and how long should I wait before I call you?
- If one value is abnormal, what happens next before any treatment changes?
- What symptoms should send me to an emergency room instead of your office?
- StatPearls, National Library of Medicine Bookshelf (2024). Central Retinal Artery Occlusion (StatPearls).
- Journal of Neurology (via PubMed Central) (2025). Risks of stroke and myocardial infarction after retinal artery occlusion and their time dependence: a systematic review and meta-analysis.
- StatPearls, National Library of Medicine Bookshelf (2023). Central Retinal Vein Occlusion (StatPearls).
- Journal of Ophthalmology (via PubMed Central) (2018). Risk of Ischemic Stroke, Hemorrhagic Stroke, and All-Cause Mortality in Retinal Vein Occlusion: A Nationwide Population-Based Cohort Study.
- MedlinePlus Genetics, National Library of Medicine (2023). Factor V Leiden thrombophilia.
- National Heart, Lung, and Blood Institute, National Institutes of Health (2022). Antiphospholipid Syndrome (APS).
- StatPearls, National Library of Medicine Bookshelf (2024). Antiphospholipid Antibody Testing (StatPearls).
- Stroke (American Heart Association) (2021). Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association.
- Blood Transfusion (via PubMed Central) (2022). Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET).
- Ophthalmology Retina (via PubMed) (2022). Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients.
- MedlinePlus, National Library of Medicine (2025). Fasting for a Blood Test.
- MedlinePlus, National Library of Medicine (2025). Homocysteine Test.
- British Journal of General Practice (via PubMed Central) (2014). Testing for thrombophilia: clinical update.
- MedlinePlus, National Library of Medicine (2024). What You Need to Know About Blood Testing.
- Blood Advances (via PubMed) (2023). American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing.